tradingkey.logo
tradingkey.logo

Movano Inc

MOVE
18.340USD
+3.550+24.00%
Close 03/27, 16:00ETQuotes delayed by 15 min
37.72MMarket Cap
LossP/E TTM

Movano Inc

18.340
+3.550+24.00%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Movano Inc

Currency: USD Updated: 2026-03-26

Key Insights

Movano Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 141 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to trend up.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Movano Inc's Score

Industry at a Glance

Industry Ranking
141 / 209
Overall Ranking
417 / 4546
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Movano Inc Highlights

StrengthsRisks
Movano Inc., doing business as Movano Health, is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade data to the forefront of consumer health devices. Its commercial product Evie Ring is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability, blood oxygen saturation, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The Company is also developing a proprietary System-on-a-Chip (SoC) designed for blood pressure or continuous glucose monitoring systems. This data is delivered through a mobile app which simplifies how data is presented and turns biometric data into actionable insights that help women make manageable lifestyle changes.
Growing
The company is in a growing phase, with the latest annual income totaling USD 1.01M.
Overvalued
The company’s latest PE is -0.09, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 76.42K shares, decreasing 48.24% quarter-over-quarter.
Held by Mairs and Power
Star Investor Mairs and Power holds 37.53K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 6.92.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
30.000
Target Price
+4801.96%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-26

The current financial score of Movano Inc is 5.19, ranking 205 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 80.00K, representing a year-over-year increase of 60.00%, while its net profit experienced a year-over-year increase of 44.05%.

Score

Industry at a Glance

Previous score
5.19
Change
0

Financials

5.57

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.82

Operational Efficiency

2.84

Growth Potential

3.63

Shareholder Returns

7.08

Movano Inc's Company Valuation

Currency: USD Updated: 2026-03-26

The current valuation score of Movano Inc is 7.49, ranking 80 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -0.09, which is -53.24% below the recent high of -0.04 and -67179.46% above the recent low of -60.28.

Score

Industry at a Glance

Previous score
7.49
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 141/209
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-26

No earnings forecast score is currently available for Movano Inc. The Healthcare Equipment & Supplies industry's average is 7.78. The average price target is 30.00, with a high of 30.00 and a low of 30.00.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
30.000
Target Price
+4801.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

92
Total
4
Median
7
Average
Company name
Ratings
Analysts
Movano Inc
MOVE
1
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
36
Edwards Lifesciences Corp
EW
35
Veeva Systems Inc
VEEV
33
Thermo Fisher Scientific Inc
TMO
29
1
2
3
...
19

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-26

The current price momentum score of Movano Inc is 8.69, ranking 20 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 17.27 and the support level at 11.68, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
8.55
Change
0.14

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
0.476
Buy
RSI(14)
70.431
Buy
STOCH(KDJ)(9,3,3)
64.594
Buy
ATR(14)
1.853
High Vlolatility
CCI(14)
278.994
Overbought
Williams %R
22.134
Buy
TRIX(12,20)
0.669
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
14.885
Buy
MA10
14.732
Buy
MA20
14.200
Buy
MA50
13.298
Buy
MA100
10.986
Buy
MA200
8.928
Buy

Institutional Confidence

Currency: USD Updated: 2026-03-26

The current institutional shareholding score of Movano Inc is 3.00, ranking 135 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 9.15%, representing a quarter-over-quarter decrease of 39.09%. The largest institutional shareholder is Mairs and Power, holding a total of 37.53K shares, representing 3.29% of shares outstanding, with 38.38% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Cogan (Jeremy D.)
5.20K
--
Appel (Peter A)
64.88K
--
Mastrototaro (John)
1.94K
--
Mairs and Power, Inc.
Star Investors
37.53K
--
Leabman Holdings LLC
37.53K
--
Fairbairn (Malcolm P.)
33.23K
-9.59%
Fairbairn Emily Wang
6.21K
+225.07%
Cullinan (Brian)
1.87K
--
1
2

Risk Assessment

Currency: USD Updated: 2026-03-26

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Movano Inc is 1.04, ranking 201 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.70. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
1.04
Change
0
Beta vs S&P 500 index
0.70
VaR
+9.68%
240-Day Maximum Drawdown
+63.31%
240-Day Volatility
+237.92%

Return

Best Daily Return
60 days
+140.17%
120 days
+149.69%
5 years
+149.69%
Worst Daily Return
60 days
-13.25%
120 days
-15.02%
5 years
-25.47%
Sharpe Ratio
60 days
+2.03
120 days
+1.63
5 years
-0.03

Risk Assessment

Maximum Drawdown
240 days
+63.31%
3 years
+97.88%
5 years
+98.45%
Return-to-Drawdown Ratio
240 days
+2.00
3 years
-0.31
5 years
-0.15
Skewness
240 days
+6.37
3 years
+7.79
5 years
+8.24

Volatility

Realised Volatility
240 days
+237.92%
5 years
+186.87%
Standardised True Range
240 days
+7.40%
5 years
+34.27%
Downside Risk-Adjusted Return
120 days
+794.30%
240 days
+794.30%
Maximum Daily Upside Volatility
60 days
+519.70%
Maximum Daily Downside Volatility
60 days
+257.92%

Liquidity

Average Turnover Rate
60 days
+37.81%
120 days
+22.34%
5 years
--
Turnover Deviation
20 days
+692.29%
60 days
+234.60%
120 days
+97.71%

Peer Comparison

Healthcare Equipment & Supplies
Movano Inc
Movano Inc
MOVE
4.56 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.64 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bioventus Inc
Bioventus Inc
BVS
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
West Pharmaceutical Services Inc
West Pharmaceutical Services Inc
WST
8.26 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.12 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI